Phase 2CompletedINTERVENTIONAL
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
ClinicalTrials.gov · NCT05892432 · Registry updated: 2025-12-26
- Condition / research focus
- Alcohol Use Disorder
- Sponsor
- University of Colorado, Denver
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2024-01-11. Completion: 2025-11-15 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Semaglutide 3 MG [Rybelsus] (drug) — also listed as: Rybelsus 3 mg
- Semaglutide 7 MG [Rybelsus] (drug) — also listed as: Rybelsus 7 mg
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- University of Colorado Anschutz Medical CampusAurora, Colorado, United States